Sfoglia per AUTORE
MARNETTO F
Collezione AOU San Luigi di Orbassano

  

Items : 29

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line. in Current issues in molecular biology / Curr Issues Mol Biol. 2022 Mar 7;44(3):1247-1256. doi: 10.3390/cimb44030083.
2022
AOU San Luigi di Orbassano

Montarolo F; Martire S; Marnetto F; Valentino P; Valverde S; Capobianco MA; Bertolotto A;

The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. in Molecular biology reports / Mol Biol Rep. 2022 Jun;49(6):4709-4718. doi: 10.1007/s11033-022-07320-5. Epub 2022 Mar 12.
2022
AOU San Luigi di Orbassano

Martire S; Valentino P; Marnetto F; Mirabile L; Capobianco M; Bertolotto A;

Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
2021
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A;

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2018 Sep 13;5(6):e498. doi: 10.1212/NXI.0000000000000498. eCollect
2018
AOU San Luigi di Orbassano

Marcinnò A; Marnetto F; Valentino P; Martire S; Balbo A; Drago A; Leto M; Capobianco M; Panzica G; Bertolotto A;

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(2):e317. doi: 10.1212/NXI.0000000000000317. eCollect
2017
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Granieri L; Capobianco M; Bertolotto A;

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. in Journal of immunological methods / J Immunol Methods. 2017 Jun;445:53-58. doi: 10.1016/j.jim.2017.03.008. Epub 2017 Mar 12.
2017
AOU San Luigi di Orbassano

Marnetto F; Valentino P; Caldano M; Bertolotto A;

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano

Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;

2015
AOU San Luigi di Orbassano

Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F;

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. in Journal of neuroinflammation / J Neuroinflammation. 2015 Aug 12;12:146. doi: 10.1186/s12974-015-0365-x.
2015
AOU San Luigi di Orbassano

Spadaro M; Caldano M; Marnetto F; Lugaresi A; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. in PloS one / PLoS One. 2015 Jun 5;10(6):e0129291. doi: 10.1371/journal.pone.0129291. eCollection 2015.
2015
AOU San Luigi di Orbassano

Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A;

CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study. in Journal of neuroimmunology / J Neuroimmunol. 2014 Dec 15;277(1-2):127-33. doi: 10.1016/j.jneuroim.2014.09.008. Epub 2014 Sep 20.
2014
AOU San Luigi di Orbassano

Marnetto F; Granieri L; Valentino P; Capobianco M; Pautasso M; Bertolotto A;

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. in PloS one / PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.
2012
AOU San Luigi di Orbassano

Granieri L; Marnetto F; Valentino P; Frau J; Patanella AK; Nytrova P; Sola P; Capobianco M; Jarius S; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. in Journal of neuroimmunology / J Neuroimmunol. 2009 Dec 10;217(1-2):74-9. doi: 10.1016/j.jneuroim.2009.10.002. Epub 2009 Oct 21.
2009
AOU San Luigi di Orbassano

Marnetto F; Hellias B; Granieri L; Frau J; Patanella AK; Nytrova P; Sala A; Capobianco M; Gilli F; Bertolotto A;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera. in Journal of immunological methods / J Immunol Methods. 2008 Jul 31;336(2):119-26. doi: 10.1016/j.jim.2008.04.002. Epub 2008 Apr 28.
2008
AOU San Luigi di Orbassano

Gilli F; van Beers M; Marnetto F; Jiskoot W; Bertolotto A; Schellekens H;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.
2006
AOU San Luigi di Orbassano

Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte